About SOUL SOUL was a multicenter, international, randomized, double-blind, parallel-group, placebo-controlled, phase 3b cardiovascular outcomes trial, with 9,650 participants enrolled
Schedule your consultation today to change to an FDA-approved medication, receive complete prior authorization support, and embark on a comprehensive weight loss journey at an insured clinic in Fort Walton Beach
Currently, Wegovy, another branded semaglutide, is the only one approved for weight loss, meaning you dont have to be a diabetic
Are you planning an IND-enabling or early clinical study for a GLP-1 therapeutic
FDA Guidelines on Long-Term Tirzepatide Use The FDA examines clinical trial data to prove that tirzepatide is safe to use beyond the initial stages
The demand for GLP-1 drugs is rising sharply, as are costs